Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $11.66 billion. The enterprise value is $11.38 billion.
| Market Cap | 11.66B |
| Enterprise Value | 11.38B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 93.86 million shares outstanding. The number of shares has increased by 5.53% in one year.
| Shares Outstanding | 93.86M |
| Shares Change (YoY) | +5.53% |
| Shares Change (QoQ) | +16.74% |
| Owned by Insiders (%) | 4.30% |
| Owned by Institutions (%) | 87.75% |
| Float | 89.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 60.14 |
| PS Ratio | 9.38 |
| Forward PS | 6.21 |
| PB Ratio | 13.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | 159.25 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.95, with a Debt / Equity ratio of 1.63.
| Current Ratio | 3.95 |
| Quick Ratio | 3.18 |
| Debt / Equity | 1.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.70% and return on invested capital (ROIC) is -11.87%.
| Return on Equity (ROE) | -69.70% |
| Return on Assets (ROA) | -17.10% |
| Return on Capital (ROIC) | -11.87% |
| Revenue Per Employee | $946,222 |
| Profits Per Employee | -$407,897 |
| Employee Count | 1,314 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 0.34 |
Taxes
In the past 12 months, SRPT has paid $15.88 million in taxes.
| Income Tax | 15.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.92% in the last 52 weeks. The beta is 0.95, so SRPT's price volatility has been similar to the market average.
| Beta (1Y) | 0.95 |
| 52-Week Price Change | -1.92% |
| 50-Day Moving Average | 125.86 |
| 200-Day Moving Average | 111.44 |
| Relative Strength Index (RSI) | 54.02 |
| Average Volume (30 Days) | 808,669 |
Short Selling Information
The latest short interest is 4.60 million, so 4.90% of the outstanding shares have been sold short.
| Short Interest | 4.60M |
| Short Previous Month | 4.97M |
| Short % of Shares Out | 4.90% |
| Short % of Float | 5.13% |
| Short Ratio (days to cover) | 5.23 |
Income Statement
In the last 12 months, SRPT had revenue of $1.24 billion and -$535.98 million in losses. Loss per share was -$5.80.
| Revenue | 1.24B |
| Gross Profit | 1.09B |
| Operating Income | -267.82M |
| Pretax Income | -520.10M |
| Net Income | -535.98M |
| EBITDA | -461.21M |
| EBIT | -520.10M |
| Loss Per Share | -$5.80 |
Balance Sheet
The company has $1.68 billion in cash and $1.40 billion in debt, giving a net cash position of $279.44 million or $2.98 per share.
| Cash & Cash Equivalents | 1.68B |
| Total Debt | 1.40B |
| Net Cash | 279.44M |
| Net Cash Per Share | $2.98 |
| Equity / Book Value | 859.34M |
| Book Value Per Share | 9.16 |
| Working Capital | 1.93B |
Cash Flow
In the last 12 months, operating cash flow was -$500.99 million and capital expenditures -$76.11 million, giving a free cash flow of -$577.10 million.
| Operating Cash Flow | -500.99M |
| Capital Expenditures | -76.11M |
| Free Cash Flow | -577.10M |
| FCF Per Share | -$6.25 |
Margins
Gross margin is 87.91%, with operating and profit margins of -21.54% and -43.11%.
| Gross Margin | 87.91% |
| Operating Margin | -21.54% |
| Pretax Margin | -41.83% |
| Profit Margin | -43.11% |
| EBITDA Margin | -37.09% |
| EBIT Margin | -41.83% |
| FCF Margin | -46.42% |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.53% |
| Shareholder Yield | -5.53% |
| Earnings Yield | -4.60% |
| FCF Yield | -4.95% |
Analyst Forecast
The average price target for SRPT is $160.82, which is 29.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $160.82 |
| Price Target Difference | 29.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 24.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of 1.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 4 |